Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tianrong Internet Products and Services Inc. (OTC: TIPS) Provides Post-Launch Update on DEPIN Token and Outlines Phase II Expansion Strategy for Depinfer
-
Viewbix: Quantum Transportation Achieves Implementation Milestone, Paving the Way for Quantum Hardware Testing
-
Collabtech Group Announces Acquisition of MediaCentric
-
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
-
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
-
Lasse Ingemann Brodt nominated for election as a new chairman of North Media at the AGM to be held on 10 April 2026. Martin Frandsen Tobberup to be appointed new Group Executive Director as of 10 Apri
-
Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
-
Glass House Brands Board of Directors Establishes Product Expansion Committee to Support New Product and Business Development
-
DEEP SEA MINERALS CORP. JOINS U.S. DEFENSE INDUSTRIAL BASE CONSORTIUM
-
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
Stallion Uranium Announces Completion of Ground Gravity Extension Survey over Coyote Corridor
-
Purpose Investments Inc. Announces Final February 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fun
-
Rio Silver Inc. Invites Investors to Meet Management at PDAC 2026, the World’s Premier Mining Convention
-
Apogee Therapeutics to Participate in Upcoming March Conferences
-
Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity
-
TopBuild to Acquire Johnson Roofing
-
Arq Schedules Fourth Quarter & Full-Year 2025 Earnings Conference Call
-
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
-
ZenaTech Wins the Morrissey Goodale 2026 Most Prolific and Proficient Acquirer Award for Growing its Drone as a Service Network
-
FuelCell Energy Announces First Quarter 2026 Results Conference Call on March 9, 2026 at 10:00 A.M. Eastern Time
-
Porosome Therapeutics Announces New Porosome-Targeted Medicines Developed Using AI
-
Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
-
Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience
-
Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
-
Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract
-
Applied Materials Awards Suppliers for Outstanding Performance
-
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
-
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
-
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
-
ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company
-
Allied Announces Renewal Of Normal Course Issuer Bid
-
PTLE Announces 1-for-80 Share Consolidation
-
Rail Vision: Quantum Transportation Advancing Toward Quantum Hardware Integration
-
GDS Announces Adjournments of Extraordinary General Meeting and Additional Shareholders Meetings to be Reconvened on March 10, 2026
-
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
-
Gilat Receives $39 Million in Orders for Sidewinder ESA Terminals
-
Learning Tree International Awarded Multi-Year Sole-Award NATO NCIA Commercial Training Services Contract – IFB-CO-423236
-
Xometry Announces CEO Succession Plan
-
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
-
Xometry Reports Record Fourth Quarter and Strong Full Year 2025 Results
-
First Watch Restaurant Group, Inc. Announces Retirement of Chief Financial Officer Mel Hope and Transition Plan
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
-
New WJ V Nonverbal Cognitive Assessment from Riverside Insights Closes Critical Gap in Student Evaluation
-
New Survey Data Reveals What Canadian Mortgage Brokers Want Most from Private Lenders… and Most Aren’t Getting It
-
Aya Gold & Silver Identifies New Parallel Structure at Boumadine and Reports High-Grade Exploration Results
-
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
-
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients
-
Canada’s Rental Market Stabilizes in 2026 — But Supply Risks Are Building
